Insulin-like growth factor binding protein-7 as a marker of cardiac reverse remodeling with empagliflozin: a secondary analysis of the empa-heart cardiolink-6 randomized controlled trial
Canadian Journal of Cardiology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要